Based on our findings, we propose a “two‐hit model” through which aging‐ and Synuclein/Tau‐ driven metabolic reprogramming events cooperate ultimately resulting in the pathological manifestations associated with AD or PD. The gene discussed is MAPT; the disease is Alzheimer disease.